One of the possible strategies to improve topical treatment adherence is the implementation of patient-centric drug product design. IMCD is developing solution concepts taking the target product profile (TPP) into account. Join our webinar where we share the reasonings behind the proper choice of topical ingredients, vehicles, and dosage forms. Following the TPP for dry skin and atopic dermatitis, we have developed patient-friendly mucopolysaccharide polysulfate (MPS) and pimecrolimus creams. By using innovative excipients, not only we have improved the stability of a metronidazole vaginal gel but formulated it into a vaginal spray with proven mucoadhesive efficacy. Join us in this webinar find out more!
A dedicated contributor to the topical ingredients field, with a solid twelve plus years of experience, including 5.5 years at IMCD. Abhishek Shukla, Sr. Product manager at IMCD is passionate about driving innovation and striving for improved patient compliance.